China Drugs for Schistosomiasis Market by Manufacturers, Regions (Province), Type and Application, Forecast to 2022

Global Info Research
120 Pages
Schistosomiasis, also known as snail fever and bilharzia, is a disease caused by parasitic flatworms called schistosomes. The urinary tract or the intestines may be infected. Signs and symptoms may include abdominal pain, diarrhea, bloody stool, or blood in the urine. Those who have been infected a long time may experience liver damage, kidney failure, infertility, or bladder cancer. In children, it may cause poor growth and learning difficulty.


Scope of the Report:
This report focuses on the Drugs for Schistosomiasis in China market, to split the market based on manufacturers, Regions (Province), type and application.

Market Segment by Manufacturers, this report covers
Shin Poong
Merck
Bayer
EIPICO
Chandra Bhagat Pharma
Taj Pharmaceuticals

Market Segment by Regions (Province), covering
South China
Southwest China
East China
Northeast China
North China

Market Segment by Type, covers
Praziquantel
Oxamniquine
Other

Market Segment by Applications, can be divided into
S. haematobium
S. mansoni
S. japonicum
S. mekongi
S. intercalatum

There are 18 Chapters to deeply display the China Drugs for Schistosomiasis market.

Chapter 1, to describe Drugs for Schistosomiasis Introduction, product type and application, market overview, market analysis by Region (province), market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Drugs for Schistosomiasis, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4,to show the China market by Regions (Province),covering South China,East China,Southwest China,North China,Northeast China,Northwest China and Central China,with sales, price,revenue and market share of Drugs for Schistosomiasis,for each region,from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7,8,9,10,11,12 and 13 to analyze the key Province by Type and Application,covering South China,East China,Southwest China,North China,Northwest China,Central China and Northeast China,with sales,revenue and market share by types and applications;

Chapter 14, Drugs for Schistosomiasis market forecast, by Regions (Province), type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022;

Chapter 15, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 16, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 17, to describe sales channel, distributors, traders, dealers etc.

Chapter 18, to describe Drugs for Schistosomiasis Appendix, methodology and data source

Table of Contents
1 Market Overview
1.1 Drugs for Schistosomiasis Introduction
1.2 Market Analysis by Type
1.2.1 Praziquantel
1.2.2 Oxamniquine
1.2.3 Other
1.3 Market Analysis by Applications
1.3.1 S. haematobium
1.3.2 S. mansoni
1.3.3 S. japonicum
1.3.4 S. mekongi
1.3.5 S. intercalatum
1.4 Market Analysis by Regions (Province)
1.4.1 South China Status and Prospect (2012-2022)
1.4.2 Southwest China Status and Prospect (2012-2022)
1.4.3 East China Status and Prospect (2012-2022)
1.4.4 Northeast China Status and Prospect (2012-2022)
1.4.5 North China Status and Prospect (2012-2022)
1.4.6 Central China Status and Prospect (2012-2022)
1.4.7 Northwest China Status and Prospect (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Shin Poong
2.1.1 Profile
2.1.2 Drugs for Schistosomiasis Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Shin Poong Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.4 Business Overview
2.1.5 Shin Poong News
2.2 Merck
2.2.1 Profile
2.2.2 Drugs for Schistosomiasis Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Merck Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.4 Business Overview
2.2.5 Merck News
2.3 Bayer
2.3.1 Profile
2.3.2 Drugs for Schistosomiasis Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Bayer Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.4 Business Overview
2.3.5 Bayer News
2.4 EIPICO
2.4.1 Profile
2.4.2 Drugs for Schistosomiasis Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 EIPICO Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.4 Business Overview
2.4.5 EIPICO News
2.5 Chandra Bhagat Pharma
2.5.1 Profile
2.5.2 Drugs for Schistosomiasis Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Chandra Bhagat Pharma Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.4 Business Overview
2.5.5 Chandra Bhagat Pharma News
2.6 Taj Pharmaceuticals
2.6.1 Profile
2.6.2 Drugs for Schistosomiasis Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Taj Pharmaceuticals Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.4 Business Overview
2.6.5 Taj Pharmaceuticals News
3 China Drugs for Schistosomiasis Market Competition, by Manufacturer
3.1 China Drugs for Schistosomiasis Sales and Market Share by Manufacturer (2016-2017)
3.2 China Drugs for Schistosomiasis Revenue and Market Share by Manufacturer (2016-2017)
3.3 China Drugs for Schistosomiasis Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Drugs for Schistosomiasis Manufacturer Market Share
3.4.2 Top 5 Drugs for Schistosomiasis Manufacturer Market Share
3.5 Market Competition Trend
4 China Drugs for Schistosomiasis Market Analysis by Regions (Province)
4.1 China Drugs for Schistosomiasis Sales Market Share by Regions (Province)
4.2 China Drugs for Schistosomiasis Sales by Regions (Province) (2012-2017)
4.3 China Drugs for Schistosomiasis Revenue (Value) by Regions (Province) (2012-2017)
5 China Market Segmentation Drugs for Schistosomiasis by Type
5.1 China Drugs for Schistosomiasis Sales, Revenue and Market Share by Type (2012-2017)
5.1.1 China Drugs for Schistosomiasis Sales and Market Share by Type (2012-2017)
5.1.2 China Drugs for Schistosomiasis Revenue and Market Share by Type (2012-2017)
5.2 Praziquantel Sales Growth and Price
5.2.1 China Praziquantel Sales Growth (2012-2017)
5.2.2 China Praziquantel Price (2012-2017)
5.3 Oxamniquine Sales Growth and Price
5.3.1 China Oxamniquine Sales Growth (2012-2017)
5.3.2 China Oxamniquine Price (2012-2017)
5.4 Other Sales Growth and Price
5.4.1 China Other Sales Growth (2012-2017)
5.4.2 China Other Price (2012-2017)
6 China Market Segmentation Drugs for Schistosomiasis by Application
6.1 China Drugs for Schistosomiasis Sales Market Share by Application (2012-2017)
6.2 S. haematobium Sales Growth (2012-2017)
6.3 S. mansoni Sales Growth (2012-2017)
6.4 S. japonicum Sales Growth (2012-2017)
6.5 S. mekongi Sales Growth (2012-2017)
6.6 S. intercalatum Sales Growth (2012-2017)
7 South China Drugs for Schistosomiasis Sales, Revenue, by Type, Application and Manufacturers
7.1 South China Drugs for Schistosomiasis Revenue, Sales and Growth Rate (2012-2017)
7.2 South China Drugs for Schistosomiasis Sales and Market Share by Type
7.3 South China Drugs for Schistosomiasis Sales by Application (2012-2017)
8 East China Drugs for Schistosomiasis Sales, Revenue, by Type, Application and Manufacturers
8.1 East China Drugs for Schistosomiasis Revenue, Sales and Growth Rate (2012-2017)
8.2 East China Drugs for Schistosomiasis Sales and Market Share by Type
8.3 East China Drugs for Schistosomiasis Sales by Application (2012-2017)
9 Southwest China Drugs for Schistosomiasis Sales, Revenue, by Type, Application and Manufacturers
9.1 Southwest China Drugs for Schistosomiasis Revenue, Sales and Growth Rate (2012-2017)
9.2 Southwest China Drugs for Schistosomiasis Sales and Market Share by Type
9.3 Southwest China Drugs for Schistosomiasis Sales by Application (2012-2017)
10 Northeast China Drugs for Schistosomiasis Sales, Revenue, by Type, Application and Manufacturers
10.1 Northeast China Drugs for Schistosomiasis Revenue, Sales and Growth Rate (2012-2017)
10.2 Northeast China Drugs for Schistosomiasis Sales and Market Share by Type
10.3 Northeast China Drugs for Schistosomiasis Sales by Application (2012-2017)
11 North China Drugs for Schistosomiasis Sales, Revenue, by Type, Application and Manufacturers
11.1 North China Drugs for Schistosomiasis Revenue, Sales and Growth Rate (2012-2017)
11.2 North China Drugs for Schistosomiasis Sales and Market Share by Type
11.3 North China Drugs for Schistosomiasis Sales by Application (2012-2017)
12 Central China Drugs for Schistosomiasis Sales, Revenue, by Type, Application and Manufacturers
12.1 Central China Drugs for Schistosomiasis Revenue, Sales and Growth Rate (2012-2017)
12.2 Central China Drugs for Schistosomiasis Sales and Market Share by Type
12.3 Central China Drugs for Schistosomiasis Sales by Application (2012-2017)
13 Northwest China Drugs for Schistosomiasis Sales, Revenue, by Type, Application and Manufacturers
13.1 Northwest China Drugs for Schistosomiasis Revenue, Sales and Growth Rate (2012-2017)
13.2 Northwest China Drugs for Schistosomiasis Sales and Market Share by Type
13.3 Northwest China Drugs for Schistosomiasis Sales by Application (2012-2017)
14 Drugs for Schistosomiasis Market Forecast (2017-2022)
14.1 China Drugs for Schistosomiasis Sales, Revenue and Growth Rate (2017-2022)
14.2 Drugs for Schistosomiasis Market Forecast by Regions (Province) (2017-2022)
14.3 Drugs for Schistosomiasis Market Forecast by Type (2017-2022)
14.4 Drugs for Schistosomiasis Market Forecast by Application (2017-2022)
15 Drugs for Schistosomiasis Manufacturing Cost Analysis
15.1 Drugs for Schistosomiasis Key Raw Materials Analysis
15.1.1 Key Raw Materials
15.1.2 Price Trend of Key Raw Materials
15.1.3 Key Suppliers of Raw Materials
15.1.4 Market Concentration Rate of Raw Materials
15.2 Proportion of Manufacturing Cost Structure
15.2.1 Raw Materials
15.2.2 Labor Cost
15.2.3 Manufacturing Expenses
15.3 Manufacturing Process Analysis of Drugs for Schistosomiasis
16 Industrial Chain, Sourcing Strategy and Downstream Buyers
16.1 Drugs for Schistosomiasis Industrial Chain Analysis
16.2 Upstream Raw Materials Sourcing
16.3 Raw Materials Sources of Drugs for Schistosomiasis Major Manufacturers in 2016
16.4 Downstream Buyers
17 Sales Channel, Distributors, Traders and Dealers
17.1 Sales Channel
17.1.1 Direct Marketing
17.1.2 Indirect Marketing
17.1.3 Marketing Channel Future Trend
17.2 Distributors, Traders and Dealers
18 Research Findings and Conclusion
19 Appendix
19.1 Methodology
19.2 Analyst Introduction
19.3 Data Source


List of Tables and Figures

Figure Drugs for Schistosomiasis Picture
Table Product Specifications of Drugs for Schistosomiasis
Figure China Sales Market Share of Drugs for Schistosomiasis by Types in 2016
Table Types of Drugs for Schistosomiasis
Figure Praziquantel Picture
Table Major Manufacturers of Praziquantel
Figure Oxamniquine Picture
Table Major Manufacturers of Oxamniquine
Figure Other Picture
Table Major Manufacturers of Other
Table China Drugs for Schistosomiasis Sales Market Share by Applications in 2016
Table Applications of Drugs for Schistosomiasis
Figure S. haematobium Picture
Figure S. mansoni Picture
Figure S. japonicum Picture
Figure S. mekongi Picture
Figure S. intercalatum Picture
Figure South China Drugs for Schistosomiasis Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest China Drugs for Schistosomiasis Revenue (Million USD) and Growth Rate (2012-2022)
Figure East China Drugs for Schistosomiasis Revenue (Million USD) and Growth Rate (2012-2022)
Figure Northeast China Drugs for Schistosomiasis Revenue (Million USD) and Growth Rate (2012-2022)
Figure North China Drugs for Schistosomiasis Revenue (Million USD) and Growth Rate (2012-2022)
Figure Central China Drugs for Schistosomiasis Revenue (Million USD) and Growth Rate (2012-2022)
Figure Northwest China Drugs for Schistosomiasis Revenue (Million USD) and Growth Rate (2012-2022)
Table Shin Poong Basic Information, Manufacturing Base and Competitors
Table Shin Poong Drugs for Schistosomiasis Type and Applications
Table Shin Poong Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Drugs for Schistosomiasis Type and Applications
Table Merck Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Drugs for Schistosomiasis Type and Applications
Table Bayer Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table EIPICO Basic Information, Manufacturing Base and Competitors
Table EIPICO Drugs for Schistosomiasis Type and Applications
Table EIPICO Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Chandra Bhagat Pharma Basic Information, Manufacturing Base and Competitors
Table Chandra Bhagat Pharma Drugs for Schistosomiasis Type and Applications
Table Chandra Bhagat Pharma Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Taj Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Taj Pharmaceuticals Drugs for Schistosomiasis Type and Applications
Table Taj Pharmaceuticals Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table China Drugs for Schistosomiasis Sales by Manufacturer (2016-2017)
Figure China Drugs for Schistosomiasis Sales Market Share by Manufacturer in 2016
Figure China Drugs for Schistosomiasis Sales Market Share by Manufacturer in 2017
Table China Drugs for Schistosomiasis Revenue by Manufacturer (2016-2017)
Figure China Drugs for Schistosomiasis Revenue Market Share by Manufacturer in 2016
Figure China Drugs for Schistosomiasis Revenue Market Share by Manufacturer in 2017
Table China Drugs for Schistosomiasis Price by Manufacturers (2016-2017)
Figure Top 3 Drugs for Schistosomiasis Manufacturer Market Share in 2016
Figure Top 3 Drugs for Schistosomiasis Manufacturer Market Share in 2017
Figure Top 5 Drugs for Schistosomiasis Manufacturer Market Share in 2016
Figure Top 5 Drugs for Schistosomiasis Manufacturer Market Share in 2017
Figure China Drugs for Schistosomiasis Sales and Growth (2012-2017)
Table China Drugs for Schistosomiasis Sales by Regions (Province) (2012-2017)
Table China Drugs for Schistosomiasis Sales Market Share by Regions (Province) (2012-2017)
Figure China 2012 Drugs for Schistosomiasis Sales Market Share by Regions (Province)
Figure China 2017 Drugs for Schistosomiasis Sales Market Share by Regions (Province)
Figure China Drugs for Schistosomiasis Revenue and Growth (2012-2017)
Table China Drugs for Schistosomiasis Revenue by Regions (Province) (2012-2017)
Table China Drugs for Schistosomiasis Revenue Market Share by Regions (Province) (2012-2017)
Table China 2012 Drugs for Schistosomiasis Revenue Market Share by Regions (Province)
Table China 2016 Drugs for Schistosomiasis Revenue Market Share by Regions (Province)
Table China Drugs for Schistosomiasis Sales by Type (2012-2017)
Table China Drugs for Schistosomiasis Sales Share by Type (2012-2017)
Table China Drugs for Schistosomiasis Revenue by Type (2012-2017)
Table China Drugs for Schistosomiasis Revenue Share by Type (2012-2017)
Figure China Praziquantel Sales Growth (2012-2017)
Figure China Praziquantel Price (2012-2017)
Figure China Oxamniquine Sales Growth (2012-2017)
Figure China Oxamniquine Price (2012-2017)
Figure China Other Sales Growth (2012-2017)
Figure China Other Price (2012-2017)
Table China Drugs for Schistosomiasis Sales by Application (2012-2017)
Table China Drugs for Schistosomiasis Sales Share by Application (2012-2017)
Figure China S. haematobium Sales Growth (2012-2017)
Figure China S. mansoni Sales Growth (2012-2017)
Figure China S. japonicum Sales Growth (2012-2017)
Figure China S. mekongi Sales Growth (2012-2017)
Figure China S. intercalatum Sales Growth (2012-2017)
Figure South China Drugs for Schistosomiasis Revenue and Growth (2012-2017)
Figure South China Drugs for Schistosomiasis Sales and Growth (2012-2017)
Table South China Drugs for Schistosomiasis Sales by Type (2012-2017)
Table South China Drugs for Schistosomiasis Sales Market Share by Type (2012-2017)
Table South China Drugs for Schistosomiasis Sales by Application (2012-2017)
Table South China Drugs for Schistosomiasis Sales Market Share by Application (2012-2017)
Figure East China Drugs for Schistosomiasis Revenue and Growth (2012-2017)
Figure East China Drugs for Schistosomiasis Sales and Growth (2012-2017)
Table East China Drugs for Schistosomiasis Sales by Type (2012-2017)
Table East China Drugs for Schistosomiasis Sales Market Share by Type (2012-2017)
Table East China Drugs for Schistosomiasis Sales by Application (2012-2017)
Table East China Drugs for Schistosomiasis Sales Market Share by Application (2012-2017)
Figure Southwest China Drugs for Schistosomiasis Revenue and Growth (2012-2017)
Figure Southwest China Drugs for Schistosomiasis Sales and Growth (2012-2017)
Table Southwest China Drugs for Schistosomiasis Sales by Type (2012-2017)
Table Southwest China Drugs for Schistosomiasis Sales Market Share by Type (2012-2017)
Table Southwest China Drugs for Schistosomiasis Sales by Application (2012-2017)
Table Southwest China Drugs for Schistosomiasis Sales Market Share by Application (2012-2017)
Figure Northeast China Drugs for Schistosomiasis Revenue and Growth (2012-2017)
Figure Northeast China Drugs for Schistosomiasis Sales and Growth (2012-2017)
Table Northeast China Drugs for Schistosomiasis Sales by Type (2012-2017)
Table Northeast China Drugs for Schistosomiasis Sales Market Share by Type (2012-2017)
Table Northeast China Drugs for Schistosomiasis Sales by Application (2012-2017)
Table Northeast China Drugs for Schistosomiasis Sales Market Share by Application (2012-2017)
Figure North China Drugs for Schistosomiasis Revenue and Growth (2012-2017)
Figure North China Drugs for Schistosomiasis Sales and Growth (2012-2017)
Table North China Drugs for Schistosomiasis Sales by Type (2012-2017)
Table North China Drugs for Schistosomiasis Sales Market Share by Type (2012-2017)
Table North China Drugs for Schistosomiasis Sales by Application (2012-2017)
Table North China Drugs for Schistosomiasis Sales Market Share by Application (2012-2017)
Figure Central China Drugs for Schistosomiasis Revenue and Growth (2012-2017)
Figure Central China Drugs for Schistosomiasis Sales and Growth (2012-2017)
Table Central China Drugs for Schistosomiasis Sales by Type (2012-2017)
Table Central China Drugs for Schistosomiasis Sales Market Share by Type (2012-2017)
Table Central China Drugs for Schistosomiasis Sales by Application (2012-2017)
Table Central China Drugs for Schistosomiasis Sales Market Share by Application (2012-2017)
Figure Northwest China Drugs for Schistosomiasis Revenue and Growth (2012-2017)
Figure Northwest China Drugs for Schistosomiasis Sales and Growth (2012-2017)
Table Northwest China Drugs for Schistosomiasis Sales by Type (2012-2017)
Table Northwest China Drugs for Schistosomiasis Sales Market Share by Type (2012-2017)
Table Northwest China Drugs for Schistosomiasis Sales by Application (2012-2017)
Table Northwest China Drugs for Schistosomiasis Sales Market Share by Application (2012-2017)
Figure China Drugs for Schistosomiasis Sales, Revenue and Growth Rate (2017 -2022)
Table China Drugs for Schistosomiasis Sales Forecast by Regions (Province) (2017-2022)
Table China Drugs for Schistosomiasis Market Share Forecast by Regions (Province) (2017-2022)
Table China Drugs for Schistosomiasis Sales Forecast by Type (2017-2022)
Table China Drugs for Schistosomiasis Market Share Forecast by Type (2017-2022)
Table China Drugs for Schistosomiasis Sales Forecast by Application (2017-2022)
Table China Drugs for Schistosomiasis Market Share Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Drugs for Schistosomiasis
Figure Manufacturing Process Analysis of Drugs for Schistosomiasis
Figure Drugs for Schistosomiasis Industrial Chain Analysis
Table Raw Materials Sources of Drugs for Schistosomiasis Major Manufacturers in 2016
Table Major Buyers of Drugs for Schistosomiasis
Table Distributors/Traders/ Dealers List

captcha Cheak Discount
 
Can't read the image? click here to refresh
* mark fields are compulsory

Asia-Pacific Wound Care Biologics Market by Manufacturers, Regions, Type and Application, Forecast to 2022

GIR 2017-08-18 Pharma & Healthcare

Wound Care Biologics is an evolving segment of the advanced wound care market, which includes enzyme...Read More

Asia-Pacific Vegetable (HPMC) Capsule Market by Manufacturers, Regions, Type and Application, Forecast to 2022

GIR 2017-08-18 Pharma & Healthcare

"Hydroxypropyl methylcellulose is a methylcellulose modified with a small amount of propylene glycol...Read More

Asia-Pacific Medical Alert Systems Market by Manufacturers, Regions, Type and Application, Forecast to 2022

GIR 2017-08-18 Pharma & Healthcare

Medical Alert Systems are the devices that are used to summon assistance by healthcare personnel or ...Read More

Report's License Type

$4480
$8960

Related Keywords

If you are facing any issues while making the payment, you can contact us on

+1-888-376-9998
sales@globalinforeports.com

We will be happy to assist you.